NS 626

Drug Profile

NS 626

Latest Information Update: 20 Jan 1997

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator NeuroSearch
  • Class Analgesics; Antiepileptic drugs; Antipsychotics; Neuroprotectants; Nootropics
  • Mechanism of Action Calcium channel antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Alzheimer's disease; Craniocerebral trauma; Psychotic disorders; Stroke

Most Recent Events

  • 20 Jan 1997 Discontinued-Preclinical for Head injuries in Denmark (Unknown route)
  • 20 Jan 1997 Discontinued-Preclinical for Head injuries in USA (Unknown route)
  • 20 Jan 1997 Discontinued-Preclinical for Psychotic disorders in Denmark (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top